Small Animal Imaging Market Price Trend Analysis And Forecast, Industry Trends, Forecast 2022-2030
Small Animal imaging Market
The small animal (in-vivo)
imaging market is expected to grow substantially during the projected period. A
variety of in-vivo techniques are used in small animal imaging operations. These
methods are gaining popularity, and they are being used to define mechanisms of
action, target receptors, and undertake epigenetic studies. Multimodal
instrument development and use has accelerated in recent years, both in
preclinical and clinical stages of research. Dual-modality or hybrid PET/CT
scanners are preferred; nevertheless, SPECT/CT scanners are currently widely
used for routine analysis.
Global small animal imaging market is estimated to be valued at US$
977.7 million in 2022 and is expected to exhibit a CAGR of 7.1% over the
forecast period (2022-2030).
Magnetic resonance imaging (MRI),
computed tomography (CT), optical imaging, ultrasound, nuclear imaging systems,
photoacoustic imaging systems, and magnetic particle imaging (MPI) systems are
all available in the Small
Animal imaging Market. Nuclear imaging systems include Micro-PET
(positron emission tomography) systems, Micro-SPECT (single-photon emission
computed tomography) systems, and Trimodality (SPECT/PET/Computed Tomography)
systems. Optical imaging systems include bioluminescence/fluorescent imaging
systems, standalone fluorescence imaging systems, and X-ray/optical imaging
systems. Scientists have successfully changed these gadgets to provide improved
image quality, offering scientists with better insights into research
programmers as technology advances. Multimodal imaging devices that combine
PET, SPECT, MRI, and CT technologies have made major contributions to
preclinical research. Research and development initiatives in medicine
development for chronic diseases such as cancer, arthritis, and others are
projected to generate demand for technologically advanced products advanced small animal imaging Market.
Small animal imaging Market are used to examine biological, biochemical, and
therapeutic processes in small animals such as rats, mice, and rabbits at the
molecular level for gene expression and medication discovery. Many micro level
medical devices have been developed from nuclear imaging technologies,
including micro MRI, micro ultrasound imaging, micro-magnetic resonance imaging
(MRI), optical imaging (bioluminescence and fluorescence imaging), and
multimodal imaging technologies, such as micro CT and micro PET.
In small animal imaging, mice are
injected with a radioactive biomolecule that targets a critical biomarker that
governs disease progression in cancer, sickle cell disease (SCD), and other
diseases. MRI, X-ray, and other imaging technologies are employed in the
creation and characterization of imaging biomarkers that aid in medication
resistance and response assessment. Rapid biomarker and small animal imaging
research is likely to fuel the growth of the global small animal imaging market. For example, according to a September
2020 article published in the journal Blood Advances, very late antigen-4
(VLA-4) has been identified as a non-invasive positron emission tomography
(PET) imaging biomarker used to detect vaso-occlusive crises in sickle cell
disease (SCD) patients in the United States.
Comments
Post a Comment